Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04875312
Other study ID # 012/003187
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date April 30, 2021
Est. completion date August 1, 2021

Study information

Verified date May 2021
Source Cairo University
Contact MANAL Ahmed El Shafei Mohamed, Lecturer
Phone 201220664518
Email Manalpt1989@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to determine the difference between the effect of Ultrasound Cavitation and Elctroacupuncture on sex hormones in obese infertile patients with poly cystic ovarian syndrome …………………………………………………………………… BACKGROUND: Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder that occurs in 6 - 10% of women at the reproductive age. It is associated with an-ovulation, infertility, hyperandrogenism, obesity and insulin resistance. Endocrine characteristics of PCOS are elevated serum concentrations of androgens and Luteinizing hormone (LH) and decreased concentrations of sex hormone binding globulin (SHBG). Ultrasound cavitation is the method in handling Subcutaneous Adipose Tissue (, especially in destroying subcutaneous fat and shaping a particular part of the body. As one of the non-surgical correction method, UC is preferred for lowering the risk of complications due to obesity. UC reported a greater decrease of the WHR, suggesting a valuable modification of fat distribution pattern, especially at the abdominal level. It improves rates of ovulation, provides higher incidence of regular menstrual cycles and lower levels of total testosterone. Acupuncture is a treatment method used in Traditional Chinese Medicine. Electroacupuncture promotes follicle development and corrects reproductive endocrine dysfunction in ovaries by regulating the functions of the hypothalamus, pituitary and ovaries


Description:

This study will be designed as prospective, randomized, single blind, experimental, pre-post test , controlled- trial study. Simple Size Calculation: I- Subjects: Forty obese infertile patients with poly cystic ovarian syndrome will participate in this study to determine the difference between the effect of Ultrasound Cavitation and Elctroacupuncture on sex hormones. They will be selected randomly from Out Patient Clinic of Aga Hospital Central, in Aga. All patients will be divided randomly into two equal groups (A&B). Group A: twenty obese infertile patients with PCO who will be treated by ultrasound cavitation, 2 times per week for 3 months with medical treatment and hypocaloric diet (1200 kcal/day) Group B: twenty obese infertile patients with PCO who will be treated by electroacupuncture, 3 times per week for 3 months with medical treatment and hypocaloric diet (1200 kcal/day) II- Instrumentations: 1. Recording data sheet (Appendix II). 2. Standard weight height scale: measure BMI 3. Tape measurement: measure waist/hip ratio. 4. Test tubes: used to collect the blood samples from obese infertile patients 5. Kites: used for assessment of serum progesterone level, testosterone, LH and FSH. 6. Abdominal ultrasongraphy: measure ovulation rate. 7. cavitation in group A 8- electroacupuncture in group B


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 40
Est. completion date August 1, 2021
Est. primary completion date July 1, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 20 Years to 35 Years
Eligibility Inclusion Criteria: 1. Their ages will be ranged between 20-35 year old. 2. Their body mass index will be ranged from 30-40 kg/m2. 3. All of them are married women. Exclusion Criteria: - Women will be excluded if they have one of the following criteria: 1. Diabetes mellitus. 2. Thyroid dysfunction. 3. Concomitant cardiovascular disorders. 4. Respiratory, renal and liver dysfunction. 5. Tubal adhesions as well as uterine abnormalities.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Ultrasound cavitation in group A
Group A: twenty obese infertile patients with PCO who will be treated by ultrasound cavitation, 2 times per week for 3 months with medical treatment and hypocaloric diet (1200 kcal/day)
Electro acupuncture in group B
Group B: twenty obese infertile patients with PCO who will be treated by electroacupuncture, 3 times per week for 3 months with medical treatment and hypocaloric diet (1200 kcal/day)

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Mohamed Abdel Hamid elgaedy

Outcome

Type Measure Description Time frame Safety issue
Primary weight It will be use weight scale to measure weight to calculate the body mass index (BMI) for each woman. up to 12 weeks
Primary waist/hip ratio: It will be use tape measurement to calculate the waist/hip ratio. up to 12 weeks
Primary Testosterone hormones : They will be use kites for assessment of level of testosterone hormones up to 12 weeks
Primary FSH Hormone They will be use kites for assessment of level of FSH hormones up to 12 weeks
Primary Lh hormones They will be use kites for assessment of level of LH hormones up to 12 weeks
Primary Progesterone hormones They will be use kites for assessment of level of progesterone hormones up to 12 weeks
Primary Height It will be use tape measurement to measure height to calculate the body mass index (BMI) for each woman. up to 12 weeks
Secondary Ovulation rate It will be use ultrasonography for measuring ovulation rate. up to 12 weeks
See also
  Status Clinical Trial Phase
Completed NCT03142633 - MicroRNA as Biomarkers for Development of Metabolic Syndrome in Women With Polycystic Ovary Syndrome
Completed NCT06158932 - A Single Group Study to Evaluate the Effects of a Myo-Inositol and D-Chiro Inositol Supplement on Symptoms Associated With Polycystic Ovary Syndrome and Hormone Imbalance N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Active, not recruiting NCT02500147 - Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS) Phase 4
Completed NCT04932070 - Berberine and Polycystic Ovary Syndrome N/A
Suspended NCT03652987 - Endocrine and Menstrual Disturbances in Women With Polycystic Ovary Syndrome (PCOS)
Completed NCT03480022 - Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS Phase 3
Active, not recruiting NCT03043924 - Functional Study of the Hypothalamus in Magnetic Resonance Imaging (MRI) in Polycystic Ovary Syndrome (PCOS) N/A
Completed NCT05246306 - Aerobic Capacity and Physical Fitness Level of Adolescents With PCOS
Completed NCT05981742 - Effects of Combined Metformin and Cabergoline in Comparison With Metformin Only Therapy on Ovarian and Hormonal Activities in Iraqi Patients With PCOS Phase 2
Completed NCT05702957 - Letrozole vs Clomiphene Citrate for Induction of Ovulation in Women With Polycystic Ovarian Syndrome Phase 2/Phase 3
Completed NCT05029492 - Effect of Visceral Manipulation on PCOS N/A
Completed NCT02924025 - Motivational Interviewing as an Intervention for PCOS N/A
Not yet recruiting NCT02255578 - Endobarrier Treatment in Women With PCOS Phase 3
Completed NCT02098668 - Mathematical Model for the Human Menstrual Cycle, Endocrinological Diseases and Fertility Treatment-PAEON N/A
Withdrawn NCT01638988 - Clomifene Citrate Versus Metformin in First-line Treatment of Infertility in Patients With Polycystic Ovary Syndrome and a Resistance to Insulin Phase 3
Not yet recruiting NCT00883259 - Metformin and Gestational Diabetes in High-risk Patients: a RCTs Phase 4
Completed NCT01462864 - Development of a Structured Education Programme for Women With Polycystic Ovary Syndrome N/A
Recruiting NCT01431352 - Letrozole Versus Chinese Herbal Medicine on Polycystic Ovary Syndrome (PCOS) N/A
Completed NCT00989781 - Mechanisms of Increased Androgen Production Among Women With Polycystic Ovary Syndrome N/A